NCT02050152

Brief Summary

The investigators are conducting a study to investigate the amnestic effects of 2 different concentrations of nitrous oxide in children before induction of anesthesia in a prospective double-blinded placebo controlled study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2013

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 22, 2013

Completed
1 month until next milestone

Study Start

First participant enrolled

May 1, 2013

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2013

Completed
4 months until next milestone

First Posted

Study publicly available on registry

January 30, 2014

Completed
12.4 years until next milestone

Results Posted

Study results publicly available

June 30, 2026

Completed
Last Updated

June 30, 2026

Status Verified

May 1, 2026

Enrollment Period

5 months

First QC Date

March 22, 2013

Results QC Date

May 27, 2026

Last Update Submit

June 24, 2026

Conditions

Keywords

AmnesiaMemoryImplicitExplicitNitrous Oxide

Outcome Measures

Primary Outcomes (1)

  • Explicit Memory

    Explicit memory will be tested during the recovery period (once the child has fully recovered from anesthesia but before discharge from hospital) by a blinded observer who will ask the child whether they smelled za bad odor while they breathed through the mask.

    After full recovery from anesthesia (generally by 2 hours after termination of anesthesia), but before discharge from hospital all variables will be assessed

Secondary Outcomes (3)

  • Explicit Memory

    After recovery from anesthesia (in recovery room or before discharge from hospital) within 4 hours of anesthesia completion

  • Explicit Memory if the Child Remembered Being Shown an Animal in a Photo

    2 hours after anesthesia

  • Explicit Memory of the Name of a Food That Begins With the Letter "b"

    2 hours after anesthesia

Study Arms (3)

Nitrous oxide 0%

PLACEBO COMPARATOR

Nitrous oxide 0% by mask for 2 minutes while showing pictures and telling jokes.

Drug: Nitrous Oxide 0%

Nitrous oxide 33%

ACTIVE COMPARATOR

Nitrous oxide 33% for 2 minutes while showing pictures and telling jokes.

Drug: Nitrous oxide 33%

Nitrous oxide 66%

ACTIVE COMPARATOR

Nitrous oxide 66% for 2 minutes while showing pictures and telling jokes.

Drug: Nitrous oxide 66%

Interventions

Behavior: recall at discharge from hospital will be tested for the content of photos and a joke told while breathing a mask

Also known as: Placebo
Nitrous oxide 0%

Behavior: recall at discharge from hospital will be tested for the content of photos and a joke told while breathing a mask

Also known as: low concentration Nitrous oxide
Nitrous oxide 33%

Behavior: recall at discharge from hospital will be tested for the content of photos and a joke told while breathing a mask

Also known as: high concentration Nitrous oxide
Nitrous oxide 66%

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age: 6-12 years old,
  • ASA classification: 1 and 2
  • Elective surgery

You may not qualify if:

  • Uncooperative child needs sedation before induction of anesthesia
  • Developmental delay, ADHD, autism, Tourette's syndrome, schizophrenia, congenital and acquired brain disorder, Down syndrome.
  • Those who request for IV induction
  • Those taking sedative medications, anti-seizure medication
  • Those with malignant hyperthermia, muscular dystrophy; those with uncorrected cardiac defects and those with severe or active lung disease
  • Those with elective admissions to PICU with ongoing sedation and tracheal intubation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Women and Children's Hospital of Buffalo

Buffalo, New York, 14222-2006, United States

Location

MeSH Terms

Conditions

Amnesia

Condition Hierarchy (Ancestors)

Memory DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental Disorders

Results Point of Contact

Title
Dr. Jerrold Lerman, Clinical Professor of Anesthesiology
Organization
Women and Children's Hospital of Buffalo, SUNY at Buffalo

Study Officials

  • Jerrold Lerman, MD, FRCPC

    Professor

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor of Anesthesiology

Study Record Dates

First Submitted

March 22, 2013

First Posted

January 30, 2014

Study Start

May 1, 2013

Primary Completion

October 1, 2013

Study Completion

October 1, 2013

Last Updated

June 30, 2026

Results First Posted

June 30, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations